We are 'shocked', 'frozen', and 'freed' by new data

Roxana Mehran

doi:10.1038/nrcardio.2012.200

We are 'shocked', 'frozen', and 'freed' by new data

Nat Rev Cardiol. 2013 Feb;10(2):68-70. doi: 10.1038/nrcardio.2012.200. Epub 2013 Jan 15.

Author

Roxana Mehran¹

Affiliation

¹ The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029, USA. roxana.mehran@mountsinai.org

PMID: 23319097
DOI: 10.1038/nrcardio.2012.200

Abstract

In 2012, results from three studies in interventional cardiology have enhanced our knowledge on the best practices to improve clinical outcomes. These trials were focused on treatment safety as well as efficacy. The optimal therapeutic strategy for patients undergoing percutaneous coronary intervention continues to evolve.

Publication types

Review

MeSH terms

Benchmarking
Clinical Trials as Topic*
Coronary Artery Bypass* / adverse effects
Coronary Artery Bypass* / mortality
Coronary Artery Disease / mortality
Coronary Artery Disease / surgery
Coronary Artery Disease / therapy*
Drug Therapy, Combination
Evidence-Based Medicine*
Humans
Intra-Aortic Balloon Pumping
Percutaneous Coronary Intervention* / adverse effects
Percutaneous Coronary Intervention* / mortality
Platelet Aggregation Inhibitors / therapeutic use
Treatment Outcome

Substances

Platelet Aggregation Inhibitors